ArticleJournal of rheumatic diseases2025
Rheumatoid factor and anti-cyclic citrullinated peptide antibody levels decline in rheumatoid arthritis patients treated with Janus kinase inhibitors or biological disease-modifying anti-rheumatic drugs.
Bo Young Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.